1.Supparatpinyo K, Khamwan C, Baosoung V, Nelson KE, Sirisanthana T: Disseminated Penicillium marneffei infection in Southeast Asia. Lancet 1994, 344(8915):110–113.
2.Thuy L, Wolbers M, Nguyen HC, Vo MQ, Nguyen TC, Nguyen PHL, Pham SL, Kozal MJ, Shikuma CM, Day JN et al: Epidemiology, Seasonality, and Predictors of Outcome of AIDS-Associated Penicillium marneffei Infection in Ho Chi Minh City, Viet Nam. Clinical Infectious Diseases 2011, 52(7):945–952.
3.Gugnani H, Fisher MC, Paliwal-Johsi A, Vanittanakom N, Singh I, Yadav PS: Role of Cannomys badius as a natural animal host of Penicillium marneffei in India. Journal of Clinical Microbiology 2004, 42(11):5070–5075.
4.Singh PN, Ranjana K, Singh YI, Singh KP, Sharma SS, Kulachandra M, Nabakumar Y, Chakrabarti A, Padhye AA, Kaufman L et al: Indigenous disseminated Penicillium marneffei infection in the state of Manipur, India: Report of four autochthonous cases. Journal of Clinical Microbiology 1999, 37(8):2699–2702.
5.Deng Z, Ribas JL, Gibson DW, Connor DH: Infections caused by Penicillium marneffei in China and Southeast Asia: review of eighteen published cases and report of four more Chinese cases. Rev Infect Dis 1988, 10(3):640–652.
6.Duong TA: Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases. Clin Infect Dis 1996, 23(1):125–130.
7.Vanittanakom N, Cooper Jr CR, Fisher MC, Sirisanthana T: Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects. Clinical Microbiology Reviews 2006, 19(1):95–110.
8.Jiang J, Meng S, Huang S, Ruan Y, Lu X, Li JZ, Wu N, Huang J, Xie Z, Liang B et al: Effects of Talaromyces marneffei infection on mortality of HIV/AIDS patients in southern China: a retrospective cohort study. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2018.
9.Son VT, Khue PM, Strobel M: Penicilliosis and AIDS in Haiphong, Vietnam: Evolution and predictive factors of death. Medecine Et Maladies Infectieuses 2014, 44(11–12):495–501.
10.Xiao J, Gao GJ, Li YM, Zhang W, Tian YF, Huang YX, Su WJ, Han N, Yang D, Zhao HX: Spectrums of Opportunistic Infections and Malignancies in HIV-Infected Patients in Tertiary Care Hospital, China. PloS one 2013, 8(10).
11.Sun HY, Chen MY, Hsiao CF, Hsieh SM, Hung CC, Chang SC: Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated with highly active anti-retroviral therapy. Clinical Microbiology and Infection 2006, 12(4):381–388.
12.Louie JK, Chi NLT, Quang VM, Campbell J, Chau NV, Rutherford GW, Farrar JJ, Parry CM: Opportunistic infections in hospitalized HIV-infected adults in Ho Chi Minh City, Vietnam: a cross-sectional study. International Journal of Std & Aids 2004, 15(11):758–761.
13.Ranjana KH, Priyokumar K, Singh TJ, Gupta CC, Sharmila L, Singh PN, Chakrabarti A: Disseminated Penicillium marneffei infection among HIV-infected patients in Manipur State, India. Journal of Infection 2002, 45(4):268–271.
14.Ning C, Lai J, Wei W, Zhou B, Huang J, Jiang J, Liang B, Liao Y, Zang N, Cao C et al: Accuracy of rapid diagnosis of Talaromyces marneffei: A systematic review and meta-analysis. PloS one 2018, 13(4).
15.Wang ZD, Wang SC, Liu HH, Ma HY, Li ZY, Wei F, Zhu XQ, Liu Q: Prevalence and burden of Toxoplasma gondii infection in HIV-infected people: a systematic review and meta-analysis. Lancet HIV 2017, 4(4):e177-e188.
16.Horman A, Korpela H, Sutinen J, Wedel H, Hanninen ML: Meta-analysis in assessment of the prevalence and annual incidence of Giardia spp. and Cryptosporidium spp. infections in humans in the Nordic countries. Int J Parasitol 2004, 34(12):1337–1346.
17.Wasserman S, Engel ME, Griesel R, Mendelson M: Burden of pneumocystis pneumonia in HIV-infected adults in sub-Saharan Africa: a systematic review and meta-analysis. BMC Infect Dis 2016, 16:482.
18.Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM, Group Q-: QUADAS–2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of internal medicine 2011, 155(8):529–536.
19.Sobanski V, Dauchet L, Lefevre G, Lambert M, Morell-Dubois S, Sy T, Hachulla E, Hatron PY, Launay D, Dubucquoi S: Prevalence of anti-RNA polymerase III antibodies in systemic sclerosis: New data from a French cohort and a systematic review and meta-analysis. Arthritis Rheumatol 2014, 66(2):407–417.
20.Pang W, Shang P, Li Q, Xu J, Bi L, Zhong J, Pei X: Prevalence of Opportunistic Infections and Causes of Death among Hospitalized HIV-Infected Patients in Sichuan, China. The Tohoku journal of experimental medicine 2018, 244(3):231–242.
21.Li YH, Li Q, Zhai YJ, Li YY, Bai JS, Huang YL, Cao YK: Drug sensitivity study and risk factor analysis of deep fungal infection among HIV/AIDS patients. Journal of Dermatology and Venereology 2018, 40(2):168–171.
22.Ni W, Yang L, Liu GZ: Distribution and drug resistance of deep fungus from AIDS patients with infection in hospital of traditional Chinese medicine. China Medical Herald 2018, 15(19):139–142.
23.Yen YF, Chen M, Jen I, Lan YC, Chuang PH, Liu YL, Lee Y, Chen YMA: Association of HIV and Opportunistic Infections With Incident Stroke: A Nationwide Population-Based Cohort Study in Taiwan. Jaids-Journal of Acquired Immune Deficiency Syndromes 2017, 74(2):117–125.
24.Kaur R, Dhakad MS, Goyal R, Bhalla P, Dewan R: Spectrum of opportunistic fungal infections in HIV/AIDS patients in tertiary care hospital in India. Canadian Journal of Infectious Diseases and Medical Microbiology 2016, 2016.
25.Qi T, Zhang R, Shen Y, Liu L, Lowrie D, Song W, Chen J, Wang Z, Shen J, Cai R et al: Etiology and clinical features of 229 cases of bloodstream infection among Chinese HIV/AIDS patients: a retrospective cross-sectional study. European Journal of Clinical Microbiology & Infectious Diseases 2016, 35(11):1767–1770.
26.Zhai ZF, Cheng LJ, Zhou CJ, Song ZQ, Yang H, Shen Z: Facial skin findings are indicators of human immunodeficiency virus infection and acquired immune deficiency syndrome: a retrospective study. Journal of Public Health-Heidelberg 2016, 24(6):505–511.
27.Zheng JD, Gui X, Cao Q, Yang RR, Yan YJ, Deng LP, Lio J: A Clinical Study of Acquired Immunodeficiency Syndrome Associated Penicillium Marneffei Infection from a NonEndemic Area in China. PloS one 2015, 10(6).
28.Kolalapudi SA, Guttikonda A: Cutaneous fungal infections in HIV infection: An Indian experience. Journal of the American Academy of Dermatology 2014, 70(5):AB108.
29.Nguyen LT, Nguyen MV, Trinh HTX: Etiology of respiratory tract infection in HIV/AIDS patients at the national hospital of tropical diseases (NHTD) Hanoi, Vietnam. Sexually Transmitted Infections 2013, 89.
30.Han J, Lun WH, Meng ZH, Huang K, Mao Y, Zhu W, Lian S: Mucocutaneous manifestations of HIV-infected patients in the era of HAART in Guangxi Zhuang Autonomous Region, China. Journal of the European Academy of Dermatology and Venereology 2013, 27(3):376–382.
31.Su GS, Wei SQ, Luo XL, Xie N, Li JY: Opportunistic infection of HIV/AIDS patients in Nanning: clinical analysis of 177 cases. Guangxi Medical Journal 2012, 34(8):1000–1001.
32.Xie N: Distribution of pathogens in blood culture of 3905 AIDS patients. Hainan Medical Journal 2012, 23(9):89–91.
33.Huang XJ, Li HY, Chen DX, Wang XC, Li ZC, Wu YS, Zhang T, Gao YQ, Wu H: Clinical analysis of skin lesions in 796 Chinese HIV-positive patients. Acta Dermato-Venereologica 2011, 91(5):552–556.
34.Huang LF, Tang XP, Cai WP, Chen XJ, Lei CL, Li LH, Zhang FC: An analysis of opportunistic infection in 762 inpafients with human immunodeficiency virus infection in Guangdong areas. Chin J Intern Med 2010, 49(8):653–656.
35.Lin CY, Sun HY, Chen MY, Hsieh SM, Sheng WH, Lo YC, Hung CC, Chang SC: Aetiology of cavitary lung lesions in patients with HIV infection. Hiv Medicine 2009, 10(3):191–198.
36.Zeng CH, Xie T, Li XQ, Liu CD, Li J, Zeng LJ, Shen SJ: Investigation and analysis of fungal infection in patients with HIV/AIDS. South China J Prev Med 2009, 35(2):46–47,50.
37.Tang GL, Liu AM, Li SP, Tang LS: Penicilliosis marneffei in people with HIV/AIDS: analysis of 99 cases. Ch in J Misdiagn 2009, 9(7):1652–1653.
38.Manosuthi W, Chaovavanich A, Tansuphaswadikul S, Prasithsirikul W, Inthong Y, Chottanapund S, Sittibusaya C, Moolasart V, Termvises P, Sungkanuparph S: Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting. The Journal of infection 2007, 55(5):464–469.
39.Tang ZR, Lu ZZ, Liu W, Chen J, Hu YY, Deng XE, Liang WX, Yang JY, Lu GG: Treatment of AIDS patients with Penicilliosis marneffei in Guangxi. Applied Prev Med 2007(01):28–30.
40.Chierakul W, Rajanuwong A, Wuthiekanun V, Teerawattanasook N, Gasiprong M, Simpson A, Chaowagul W, White NJ: The changing pattern of bloodstream infections associated with the rise in HIV prevalence in northeastern Thailand. Trans R Soc Trop Med Hyg 2004, 98(11):678–686.
41.Subsai K, Kanoksri S, Siwaporn C, Helen L: Neurological complications in AIDS patients: the 1-year retrospective study in Chiang Mai University, Thailand. European Journal of Neurology 2004, 11(11):755–759.
42.Chariyalertsak S, Sirisanthana T, Saengwonloey O, Nelson KE: Clinical presentation and risk behaviors of patients with acquired immunodeficiency syndrome in Thailand, 1994–1998: Regional variation and temporal trends. Clinical Infectious Diseases 2001, 32(6):955–962.
43.Wananukul S, Thisyakorn U: Mucocutaneous manifestations of HIV infection in 91 children born to HIV-Seropositive women. Pediatric Dermatology 1999, 16(5):359–363.
44.Jing W, Ismail R: Mucocutaneous manifestations of HIV infection: a retrospective analysis of 145 cases in a Chinese population in Malaysia. International Journal of Dermatology 1999, 38(6):457–463.
45.Tansuphasawadikul S, Amornkul PN, Tanchanpong C, Limpakarnjanarat K, Kaewkungwal J, Likanonsakul S, Eampokalap B, Naiwatanakul T, Kitayaporn D, Young NL et al: Clinical presentation of hospitalized adult patients with HIV infection and AIDS in Bangkok, Thailand. Journal of Acquired Immune Deficiency Syndromes 1999, 21(4):326–332.
46.Limper AH, Adenis A, Le T, Harrison TS: Fungal infections in HIV/AIDS. The Lancet Infectious diseases 2017, 17(11):e334-e343.
47.Lu S, Li X, Calderone R, Zhang J, Ma J, Cai W, Xi L: Whole blood Nested PCR and Real-time PCR amplification of Talaromyces marneffei specific DNA for diagnosis. Medical mycology 2016, 54(2):162–168.
48.Hien HTA, Thanh TT, Thu NTM, Nguyen A, Thanh NT, Lan NPH, Simmons C, Shikuma C, Chau NVV, Thwaites G et al: Development and evaluation of a real-time polymerase chain reaction assay for the rapid detection of Talaromyces marneffei MP1 gene in human plasma. Mycoses 2016, 59(12):773–780.
49.Global HIV & AIDS statistics—2019 fact sheet [https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf
50.Bulterys PL, Le T, Quang VM, Nelson KE, Lloyd-Smith JO: Environmental predictors and incubation period of AIDS-associated penicillium marneffei infection in Ho Chi Minh City, Vietnam. Clin Infect Dis 2013, 56(9):1273–1279.
51.Changhong Zeng TX, Xiqing Li, Chudian Liu, Jie Li, Lijun Zeng, Shaojun Shen: Investigation and Analysis of HIV/AIDS Complicated with Fungal Infection. South China Journal of Preventive Medicine 2009, 35(2):46–50.
52.Hu Y, Zhang J, Li X, Yang Y, Zhang Y, Ma J, Xi L: Penicillium marneffei infection: an emerging disease in mainland China. Mycopathologia 2013, 175(1–2):57–67.
53.Li Y, Lin Z, Shi X, Mo L, Li W, Mo W, Yang Z: Retrospective analysis of 15 cases of Penicillium marneffei infection in HIV-positive and HIV-negative patients. Microb Pathog 2017, 105:321–325.
54.Manosuthi W, Chaovavanich A, Tansuphaswadikul S, Prasithsirikul W, Inthong Y, Chottanapund S, Sittibusaya C, Moolasart V, Termvises P, Sungkanuparph S: Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting. Journal of Infection 2007, 55(5):464–469.
55.Chariyalertsak S, Supparatpinyo K, Sirisanthana T, Nelson KE: A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand. Clinical Infectious Diseases 2002, 34(2):277–284.
56.Towards universal access: Scaling up priority HIV/AIDS interventions in the health sector [https://www.who.int/hiv/pub/tuapr_2009_en.pdf?ua = 1]
57.Antinori S, Gianelli E, Bonaccorso C, Ridolfo AL, Croce F, Sollima S, Parravicini C: Disseminated Penicillium marneffei infection in an HIV-positive Italian patient and a review of cases reported outside endemic regions. J Travel Med 2006, 13(3):181–188.